Properly Valuing Investment in the Development of Gene Replacement Therapy
12 Pages Posted: 8 May 2019
Date Written: March 2019
Gene Therapy represents a dramatically different approach to the disease treatment, promising complete cures rather than the management of chronic illnesses. Because of this the standard payment models used by insurance markets may not work effectively, leading to moral hazard problems and a potential under-investment in such treatments.
Keywords: drug prices, insurance, cost-benefit analysis
JEL Classification: I11, I13
Suggested Citation: Suggested Citation